Fig. 8

piRNA-14633 promotes proliferation of cervical cancer cells via METTL14 binding. a CCK-8 assay was used to assess viability in cells transfected with 50 nM mi-14633 or co-transfected with 50 nM si-METTL14#1/2. b, c Colony formation assay was used to assess cell proliferation. d, e Flow cytometry was used to analyze cell cycle. *P < 0.05 vs. mi-NC group. ^#P < 0.05 vs. mi-14633 + si-NC group. mi-14633 piRNA-14633 mimic, in-14633 piRNA-14633 inhibitor, si-NC siRNA-negtive control, si-METTL14#1/2 siRNA-METTL14#1/2